Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Disease    save search

Alzheimer's disease therapeutics market size to increase by USD 3.99 billion; North America to account for 37% of market growth - Technavio
Published: 2023-02-08 (Crawled : 01:00) - prnewswire.com
BIIB | News A | $285.45 -2.05% -2.05% 500K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
DNLI | News | $30.49 -4.6% -4.79% 390K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TEVJF | News | $9.61 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
VTRS | News | $11.92 -1.57% -1.59% 4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVSEF | News | $84.61 2.27% 180K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABBV | News | $144.61 -0.37% 1.07% 4.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GIFLF | News | $12.3904 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GIKLY | News | $7.34 4.12% 0 twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist
NVS | News | $86.89 0.64% 0.82% 1.7M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

america disease for alzheimer's therapeutics growth market
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
Published: 2023-02-08 (Crawled : 00:00) - globenewswire.com
GILD | News M | $85.67 -0.44% -0.42% 5.9M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GLPG | News | $43.58 0.42% 0.41% 81K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GLPGF | News | $40.87 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

disease topline trial results
Bacterial disease diagnostics market size to grow by USD 3.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
Published: 2023-02-08 (Crawled : 00:00) - prnewswire.com
ABT | News | $110.2 -1.6% 0.27% 3.3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
VIVO | News | $33.97 0.0% 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

disease diagnostics market
Cassava Sciences Announces Patient Enrollment Update for Phase 3 Studies of Simufilam for the Treatment of Alzheimer’s Disease
Published: 2023-02-08 (Crawled : 14:20) - globenewswire.com
SAVA | News | $29.51 -1.24% -1.32% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.98% H: 5.42% C: -1.24%

treatment sciences disease for alzheimer’s update
Annovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
Published: 2023-02-08 (Crawled : 13:00) - prnewswire.com
ANVS | News | $19.14 1.16% 4.55% 41K twitter stocktwits trandingview |
Health Technology
| | O: 1.1% H: 0.0% C: 0.0%

treatment disease for parkinson's buntanetap trial approval study
Aldeyra Therapeutics Announces FDA Acceptance of New Drug Application for Reproxalap for the Treatment of Dry Eye Disease
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
ALDX | $6.52 -3.69% -3.36% 530K twitter stocktwits trandingview |
Health Technology
| | O: 8.04% H: 0.0% C: 0.0%

treatment fda drug disease for eye application therapeutics reproxalap
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
RCKT | $19.97 -4.91% -5.11% 770K twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.0% C: 0.0%

fda pharmaceuticals designation disease for therapy rp-a501 rmat danon disease
CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day
Published: 2023-02-07 (Crawled : 12:20) - biospace.com/
CNTG | $1.34 -6.29% -2.99% 10K twitter stocktwits trandingview |
Commercial Services
| Email alert Add to watchlist

day rare disease
Satellos Bioscience Announces Significant Increase in Muscle Size and Function in Duchenne Muscular Dystrophy Disease Model
Published: 2023-02-06 (Crawled : 17:00) - biospace.com/
MSCLF | $0.3065 2.17% 51K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist

disease duchenne bioscience
Janssen Reports Positive Topline Phase 2 Results for Nipocalimab in Pregnant Individuals at High Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Published: 2023-02-06 (Crawled : 15:00) - biospace.com/
JNJ | News | $163.61 0.13% 0.27% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.75% H: 0.0% C: 0.0%

risk disease for topline positive results
HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease
Published: 2023-02-06 (Crawled : 15:00) - biospace.com/
HSCS | $2.67 -2.56% -3.4% 550K twitter stocktwits trandingview |
n/a
| | O: 106.34% H: 5.46% C: -4.44%

myovista patent disease for heart technology granted international
Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease
Published: 2023-02-06 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0945 2.16% 530K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
ENDP | $0.2926 -9.6% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

disease
Global Probiotics Business Market Report 2023: Market to Reach $91.7 Billion by 2030 - Rising Focus on Disease Prevention than Treatment and Probiotics' Potential
Published: 2023-02-03 (Crawled : 17:00) - prnewswire.com
GIS F | $75.74 -0.75% 0.36% 1.9M twitter stocktwits trandingview |
Consumer Non-Durables
| | O: 0.75% H: 0.0% C: 0.0%

treatment global disease report potential market
Global Enteric Disease Testing Market Report to 2027 - Players Include Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience and Quest Diagnostics
Published: 2023-02-02 (Crawled : 23:00) - prnewswire.com
DHR | News A | $261.94 -1.53% 0.71% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.0% C: 0.0%
ABT | News | $110.2 -1.6% 0.27% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.29% H: 0.0% C: 0.0%

global disease report diagnostics bioscience market
New Paper Highlights Clinical Utility of Natera’s Renasight™ Test in the Management of Kidney Disease
Published: 2023-02-02 (Crawled : 16:00) - biospace.com/
NTRA S | $43.88 -4.44% -4.65% 810K twitter stocktwits trandingview |
Health Services
| | O: 2.34% H: 5.02% C: 3.44%

management disease test kidney
Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio, Inc.
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
TNXP | $1.23 4.24% 2.48% 4M twitter stocktwits trandingview |
Health Technology
| | O: -1.69% H: 0.0% C: 0.0%

acquisition pharmaceuticals disease preclinical
The Worldwide Cardiovascular Disease Monitoring and Diagnostic Devices Industry is Projected to Reach $3.36 Billion by 2030 - ImplanTable Loop Recorder (ILR) to Register the Fastest Growth
Published: 2023-02-01 (Crawled : 22:00) - prnewswire.com
MDT | News F | $86.16 -0.49% 0.09% 4.6M twitter stocktwits trandingview |
Health Technology
| | O: 2.26% H: 0.0% C: 0.0%
BSX | News | $47.59 -1.04% 0.44% 4.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.0% C: 0.0%

disease diagnostic cardiovascular growth
Athira Pharma Announces Publication in Journal of Alzheimer’s Disease Highlighting Need for Novel Alzheimer’s Disease Treatment Approaches and Potential of Enhancing HGF/MET Pathway
Published: 2023-02-01 (Crawled : 12:20) - globenewswire.com
ATHA | $3.54 -3.54% -3.67% 190K twitter stocktwits trandingview |
Health Technology
| | O: -1.47% H: 9.43% C: 4.71%

treatment pharma disease for alzheimer’s potential publication hgf/met pathway fosgonimeton
XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
Published: 2023-02-01 (Crawled : 12:00) - xortx.com
XRTX | $0.668 7.74% -10.17% 160K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
| | O: 12.03% H: 2.69% C: -1.54%

designation drug disease for kidney program xrx-008 submission
Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)
Published: 2023-01-31 (Crawled : 00:00) - globenewswire.com
MESO | News | $4.18 1.7% 1.91% 310K twitter stocktwits trandingview |
Health Technology
| | O: 9.42% H: 3.61% C: -0.28%

fda disease for children application license
Gainers vs Losers
57% 43%

Top 10 Gainers
CZOO | $0.2001 -16.63% 1839.03% 3.3M twitter stocktwits trandingview |

AVRO | $1.69 93.7% 54.08% 38M twitter stocktwits trandingview |
Health Technology

CELZ | $1.04 101.04% 50.26% 140M twitter stocktwits trandingview |

GFAI | $0.5408 58.36% 36.88% 89M twitter stocktwits trandingview |

KPRX | $6.94 52.53% 34.15% 36M twitter stocktwits trandingview |
Manufacturing

PRFX | $0.7236 44.72% 30.07% 14M twitter stocktwits trandingview |
Health Technology

BJDX | $0.64 37.16% 23.51% 2.8M twitter stocktwits trandingview |

SOUN 4 | $4.63 28.61% 22.08% 62M twitter stocktwits trandingview |

THCH | News | $5.3 26.19% 19.69% 750K twitter stocktwits trandingview |
n/a

VQS | $0.5285 28.9% 19.61% 2.1M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.